Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
Infante A, Alcorta-Sevillano N, Macías I, Cabodevilla L, Medhat D, Lafaver B, Crawford TK, Phillips CL, Bueno AM, Sagastizabal B, Arroyo M, Campino A, Gerovska D, Araúzo-Bravo M, Gener B, Rodríguez CI.
Infante A, et al. Among authors: rodriguez ci.
Biomed Pharmacother. 2024 May 13;175:116725. doi: 10.1016/j.biopha.2024.116725. Online ahead of print.
Biomed Pharmacother. 2024.
PMID: 38744219